MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia

被引:5
|
作者
Bonometti, Arturo [1 ]
Ferrario, Giuseppina [2 ]
Parafioriti, Antonina [3 ]
Giardino, Demostene [4 ]
Simonetti, Federico [5 ]
Ginori, Alessandro [6 ]
Passoni, Emanuela [7 ]
Berti, Emilio [7 ,8 ]
机构
[1] Univ Pavia, Dept Mol Med, IRCCS San Matteo Fdn, Unit Anat Pathol, Pavia, Italy
[2] Univ Pavia, Dept Mol Med, IRCCS San Matteo Fdn, Pavia, Italy
[3] ASST PINI CTO Ctr Specialist Ortoped Traumatol Ga, Dept Pathol, Milan, Italy
[4] Casa Cura San Camillo, Surg Pathol Unit, Forte Dei Marmi, Italy
[5] Unico Versilia Hosp, Dept Hematol, Camaiore, Italy
[6] Azienda USL Toscana Nord Ovest, Pathol Unit, Polyspecialist Ctr Monterosso, Carrara, Italy
[7] Osped Maggiore Policlin, Dept Dermatol, Fdn IRCCS Ca Granda, Milan, Italy
[8] Univ Milan, Dept Pathophysiol & Transplantat, IRCCS Fdn, Ca Granda Osped Maggiore Policlin, Milan, Italy
关键词
Langerhans cell histiocytosis; Rosai‐ Dorfman‐ Destombes disease; Erdheim‐ Chester disease; clonal relation; acute myeloid leukemia; MUTATIONS; LYMPHOMA;
D O I
10.1111/cup.13918
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mixed histiocytoses are a rare and recently recognized subset of histiocytic disorders that may involve the skin, characterized by the synchronous or metachronous development of lesions with Langerhans and/or non-Langerhans cell histiocytosis histopathological features. Around 10% of patients diagnosed with histiocytosis may develop a hematological malignancy, often with dramatic prognostic consequences. We hereby describe the exceptional case of a patient developing a MAP2K1-driven mixed histiocytosis with Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease, and Erdheim-Chester disease features and cutaneous involvement, progressing to a fatal and clonally-related acute myeloid leukemia. We reviewed the literature on similar cases and discussed the histopathological difficulties in their diagnosis and their clinical-pathological features.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 13 条
  • [1] Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders
    Papo, Matthias
    Cohen-Aubart, Fleur
    Trefond, Ludovic
    Bauvois, Adeline
    Amoura, Zahir
    Emile, Jean-Francois
    Haroche, Julien
    CURRENT ONCOLOGY REPORTS, 2019, 21 (07)
  • [2] Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders
    Matthias Papo
    Fleur Cohen-Aubart
    Ludovic Trefond
    Adeline Bauvois
    Zahir Amoura
    Jean-François Emile
    Julien Haroche
    Current Oncology Reports, 2019, 21
  • [3] FDG PET/CT in Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease
    Ngo, Victoria T.
    Wassef, Heidi R.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (08) : 732 - 735
  • [4] Erdheim-Chester disease and Rosai-Dorfman disease. Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis
    Boesmueller, H.
    Nann, D.
    Horger, M.
    Fend, F.
    PATHOLOGE, 2015, 36 (05): : 458 - 465
  • [5] Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1
    Razanamahery, Jerome
    Diamond, Eli L.
    Cohen-Aubart, Fleur
    Plate, Karl-Heinz
    Lourida, Giota
    Charlotte, Frederic
    Helias-Rodzewicz, Zofia
    Goyal, Gaurav
    Go, Ronald S.
    Dogan, Ahmet
    Abdel-Wahab, Omar
    Durham, Benjamin
    Ozkaya, Neval
    Amoura, Zahir
    Emile, Jean-Francois
    Haroche, Julien
    HAEMATOLOGICA, 2020, 105 (01) : E5 - E8
  • [6] Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis
    Ocak, Suheyla
    Bayramoglu, Zuhal
    Tugcu, Deniz
    Karaman, Serap
    Unuvar, Aysegul
    Karakas, Zeynep
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (03) : E375 - E379
  • [7] Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia
    Ghobadi, Armin
    Miller, Christopher A.
    Li, Tiandao
    O'Laughlin, Michelle
    Lee, Yi-Shan
    Ali, Mohga
    Westervelt, Peter
    DiPersio, John F.
    Wartman, Lukas
    HAEMATOLOGICA, 2019, 104 (08) : E373 - E375
  • [8] Trametinib for a child with refractory Rosai-Dorfman-Destombes disease harboring a novel somatic mutation in MAP2K1
    Taneyama, Yuichi
    Morimoto, Akira
    Ochiai, Hidemasa
    Ando, Kumiko
    Kakuda, Harumi
    Naruke, Yuki
    Yokoi, Sana
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (04) : 520 - 524
  • [9] Combined Erdheim-Chester Disease and Langerhans Cell Histiocytosis in the Lung: A Report of 2 Patients With Overlap Syndrome
    Pires, Yumay
    Jokerst, Clinton E.
    Panse, Prasad M.
    Kipp, Benjamin R.
    Tazelaar, Henry D.
    AJSP-REVIEWS AND REPORTS, 2020, 25 (01): : 33 - 39
  • [10] Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease
    Varadi, Zsofia
    Banusz, Rita
    Csomor, Judit
    Kallay, Krisztian
    Varga, Edit
    Kertesz, Gabriella
    Csoka, Monika
    ONCOTARGETS AND THERAPY, 2017, 10 : 521 - 526